This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Catalent France Beinheim Sa, Endotis Pharma. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Nathalie Sicre: Innovator in Pharmaceutical Formulations
Introduction
Nathalie Sicre is a notable inventor based in Haguenau, France. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral dosage forms. Her innovative work focuses on synthetic oligosaccharides and their therapeutic applications.
Latest Patents
Nathalie Sicre holds one patent titled "Pharmaceutical oral dosage form containing a synthetic oligosaccharide." This invention pertains to a pharmaceutical formulation intended for oral administration, which includes a synthetic oligosaccharide containing one to 18 monosaccharide units. The formulation is designed to have therapeutic activity and includes various components such as a lipophilic phase, surfactants, and optional hydrophilic solvents. The careful balance of these ingredients aims to enhance the efficacy and stability of the pharmaceutical product.
Career Highlights
Throughout her career, Nathalie has worked with prominent companies in the pharmaceutical industry. Notable among these are Endotis Pharma and Catalent France Beinheim SA. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical formulations and contribute to innovative solutions in the field.
Collaborations
Nathalie has collaborated with several professionals in her field, including Julien Meissonnier and Guillaume Sabate. These collaborations have likely enriched her work and expanded the impact of her inventions.
Conclusion
Nathalie Sicre is a pioneering inventor whose work in pharmaceutical formulations showcases her commitment to innovation and therapeutic advancements. Her contributions continue to influence the industry and improve patient care through effective oral dosage forms.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile